Pharmstandard International S.A.
Overview
Pharmstandard International S.A. is a venture investment company focused on innovative medicines and therapies with strong global potential.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TearSolutions | Dec 2017 | Series B | Lead |
| Avelas Biosciences | Aug 2016 | Series C | Lead |
| OncoTartis, Inc. | Dec 2017 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pharmstandard International S.A. based?
Pharmstandard International S.A. is headquartered in Luxembourg.
When was Pharmstandard International S.A. founded?
Pharmstandard International S.A. was founded in 2010.
How many portfolio companies does Pharmstandard International S.A. have?
Pharmstandard International S.A. has 3 portfolio companies in Caplight's dataset.
What are some companies in Pharmstandard International S.A.'s portfolio?
Portfolio companies visible on Caplight include TearSolutions, Avelas Biosciences, OncoTartis, Inc..
What was Pharmstandard International S.A.'s most recent investment shown here?
Pharmstandard International S.A.'s most recent investment in this portfolio sample was in OncoTartis, Inc. in 2017.
What sectors does Pharmstandard International S.A. focus on?
Pharmstandard International S.A. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Pharmstandard International S.A. focus on?
Pharmstandard International S.A. typically invests at the Mid stage.